Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Methodology|Interests|Funding|Corrections
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Bibliographic record

Effects of GLP-1 and other gut hormone receptors on the gastrointestinal tract and implications in clinical…

Camilleri M, Lupianez-Merly C. American Journal of Gastroenterology 2024

Document identifier
CEI-BR-007
Series
Bibliographic record
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Bibliographic record

§1.1Record

Authors
Camilleri M, Lupianez-Merly C
Title
Effects of GLP-1 and other gut hormone receptors on the gastrointestinal tract and implications in clinical practice
Source
American Journal of Gastroenterology
Year
2024
Volume, issue, pages
119(6):1028–1037
Digital object identifier
10.14309/ajg.0000000000002519
PubMed identifier
37855681
Record type
Journal article
Institute identifier
CEI-BR-007

§1.2Institute documents citing this record

No Institute document currently cites this record. It is held in the bibliography because it was retrieved during a search and assessed, and the Institute records what it assessed and did not use as well as what it used.

§1.3Subject tags

glp-1 gastrointestinal safety

Compound Evidence Institute · CEI-BR-007 · https://compoundevidence.com/bibliography/camilleri2024/ · retrieved 30 July 2026
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.